Shangpharma Corp Stock Net Income
ShangPharma Corp fundamentals help investors to digest information that contributes to ShangPharma Corp's financial success or failures. It also enables traders to predict the movement of ShangPharma Stock. The fundamental analysis module provides a way to measure ShangPharma Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ShangPharma Corp stock.
ShangPharma |
ShangPharma Corp Company Net Income Analysis
ShangPharma Corp's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current ShangPharma Corp Net Income | 11.11 M |
Most of ShangPharma Corp's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ShangPharma Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, ShangPharma Corp reported net income of 11.11 M. This is much higher than that of the sector and significantly higher than that of the Pharmaceutical Products industry. The net income for all United States stocks is notably lower than that of the firm.
ShangPharma Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ShangPharma Corp's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ShangPharma Corp could also be used in its relative valuation, which is a method of valuing ShangPharma Corp by comparing valuation metrics of similar companies.ShangPharma Corp is currently under evaluation in net income category among its peers.
ShangPharma Fundamentals
| Return On Asset | 0.02 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 86.32 M | |||
| Shares Outstanding | 335.54 M | |||
| Number Of Shares Shorted | 17.53 K | |||
| Price To Earning | 48.93 X | |||
| Price To Book | 1.16 X | |||
| Price To Sales | 1.29 X | |||
| Revenue | 111.6 M | |||
| Gross Profit | 36.1 M | |||
| EBITDA | 22.78 M | |||
| Net Income | 11.11 M | |||
| Cash And Equivalents | 40.34 M | |||
| Cash Per Share | 1.85 X | |||
| Total Debt | 754.98 K | |||
| Debt To Equity | 0.26 % | |||
| Current Ratio | 2.78 X | |||
| Cash Flow From Operations | 18.28 M | |||
| Short Ratio | 0.20 X | |||
| Earnings Per Share | 0.18 X | |||
| Price To Earnings To Growth | 1.33 X | |||
| Number Of Employees | 2.08 K | |||
| Beta | 1.43 | |||
| Market Capitalization | 135.41 M | |||
| Total Asset | 166.9 M | |||
| Retained Earnings | 33.01 M | |||
| Working Capital | 41.6 M | |||
| Current Asset | 72.35 M | |||
| Current Liabilities | 30.74 M |
Pair Trading with ShangPharma Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ShangPharma Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ShangPharma Corp will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Sempra Energy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sempra Energy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sempra Energy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sempra Energy to buy it.
The correlation of Sempra Energy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sempra Energy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sempra Energy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sempra Energy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in ShangPharma Stock
If you are still planning to invest in ShangPharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ShangPharma Corp's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |